APA (7th ed.) Citation

Laborde, L., Mazières, J., Barlesi, F., Fieschi, J., Pérol, M., Leca, V., . . . Bory, P. (2023). 782-C Regulatory T-cell tumor infiltration is associated to better outcome in advanced NSCLC patients under ≥2nd line anti-PD1/L1 monotherapy in the PIONeeR project. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Laborde, Lilian, et al. 782-C Regulatory T-cell Tumor Infiltration Is Associated to Better Outcome in Advanced NSCLC Patients Under ≥2nd Line Anti-PD1/L1 Monotherapy in the PIONeeR Project. BMJ Publishing Group, 2023.

MLA (9th ed.) Citation

Laborde, Lilian, et al. 782-C Regulatory T-cell Tumor Infiltration Is Associated to Better Outcome in Advanced NSCLC Patients Under ≥2nd Line Anti-PD1/L1 Monotherapy in the PIONeeR Project. BMJ Publishing Group, 2023.